Fasoracetam
| Fasoracetam | |
|---|---|
 |
| Salts [] | |
|---|---|
| Fasoracetam monohydrate | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 196.25 g/mol [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H16N2O2 [1] |
| IUPAC name | (5R)-5-(piperidine-1-carbonyl)pyrrolidin-2-one [1] |
| SMILES | C1CCN(CC1)C(=O)[C@H]2CCC(=O)N2 [1] |
| InChI | InChI=1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1 [1] |
| InChIKey | GOWRRBABHQUJMX-MRVPVSSYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 4 – 6.5 hours |
Fasoracetam (also known as N-(5-Oxo-D-prolyl)piperidine, NS 105, NS-105, 1-((5-Oxo-2-pyrrolidinyl)carbonyl)piperidine, Nfc1 anhydrous, Nfc-1 anhydrous, LAM-105, Lam105 anhydrous, Lam-105 anhydrous or AEVI001) is a
Chemistry
Salts []
Fasoracetam is typically found in the form of its monohydrate salt.
Stereochemistry []
Fasoracetam is a absolute mixture.
Druglikeness
Lipinski's rule of five
Fasoracetam matches Lipinski's rule of five.Legal status []
- United States: Fasoracetam is a Not FDA-approved substance.
- Australia: Fasoracetam is a S4 substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 198695, Fasoracetam. Accessed June 11, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/198695
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fasoracetam. UNII: 42O8UF5CJB. Global Substance Registration System. Accessed June 11, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/42O8UF5CJB